Cargando…
Modulation of specificity protein 1 by mithramycin A as a novel therapeutic strategy for cervical cancer
Cervical cancer is the third most common cancer and the third leading cause of death among women. However, the standard treatment for cervical cancer includes cisplatin, which can cause side effects such as hematological damage or renal toxicity. New innovations in cervical cancer treatment focus on...
Autores principales: | Choi, Eun-Sun, Nam, Jeong-Seok, Jung, Ji-Youn, Cho, Nam-Pyo, Cho, Sung-Dae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241519/ https://www.ncbi.nlm.nih.gov/pubmed/25418289 http://dx.doi.org/10.1038/srep07162 |
Ejemplares similares
-
Mithramycin A induces apoptosis by regulating the mTOR/Mcl-1/tBid pathway in androgen-independent prostate cancer cells
por: Choi, Eun-Sun, et al.
Publicado: (2013) -
Mithramycin interacts with core histones and modulates epigenetic modifications
por: Banerjee, Amrita, et al.
Publicado: (2013) -
The Apoptotic Effect of the Hexane Extract of Rheum undulatum L. in Oral Cancer Cells through the Down-regulation of Specificity Protein 1 and Survivin
por: Choi, Eun-Sun, et al.
Publicado: (2011) -
Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia
por: Capretto, Lorenzo, et al.
Publicado: (2012) -
Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer
por: Malek, Anastasia, et al.
Publicado: (2012)